Immunocompromised populations develop a lower immunogenic response to COVID-19 vaccines, leaving them at a higher risk of severe disease, hospitalization, and death. Patients with HIV who have low ...
July 30, 2010 (Vienna, Austria) — Although initiation of highly active antiretroviral therapy (HAART) against HIV is associated with a lower risk for progression to AIDS, and a lower risk for ...
People with HIV who have moderate immune suppression appear to be at greater risk of severe COVID-19 “breakthrough” infection after vaccination, according to a study led by researchers at the Johns ...
Living with HIV means becoming fluent in a language of numbers that might seem confusing at first but actually hold the key to your health and future. Two numbers in particular – your viral load and ...
Our data demonstrates that among patients initiating therapy in RLS with (mainly) an NNRTI-based regimen, CD4 cell count recovery is impaired in the presence of on-going HIV-RNA replication over an 18 ...
At presentation, all children living with HIV younger than five years should be considered as having advanced HIV disease unless they have received ART ...
Accurate monitoring of CD4 + T cell counts is vital for evaluating immune health and guiding treatment in people living with Human Immunodeficiency Virus (HIV). Yet conventional tools like flow ...
Dr Sension underlines the value of CD4 recovery from payer and clinician perspectives. Ryan Haumschild, PharmD, MS, MBA: It’s important that we talk about CD4 recovery and how it’s important to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback